Viewing Study NCT04223661


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-01-27 @ 9:06 PM
Study NCT ID: NCT04223661
Status: WITHDRAWN
Last Update Posted: 2022-12-08
First Post: 2019-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy
Sponsor: Attaya Suvannasankha
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View